NOVEL NAPHTHYRIDINES AND ISOQUINOLINES AND THEIR USE AS CDK8/19 INHIBITORS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160016951A1
SERIAL NO

14802042

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to naphthyridine and isoquinoline compounds, and pharmaceutically acceptable compositions thereof, useful as inhibitors of CDK8/19, and for the treatment of CDK8/19-related disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CANCER RESEARCH TECHNOLOGY LIMITED2 REDMAN PLACE LONDON E20 1JQ UNITED KINGDOM

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BLAGG, Julian Surrey, GB 38 192
HONEY, Mark Kent, GB 1 41
MALLINGER, Aurelie Affleville, FR 5 44
RINK, Christian Bonn, DE 4 43
SCHIEMANN, Kai Seeheim-Jugenheim, DE 73 870
SEJBERG, Jimmy London, GB 5 46

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation